WCM Investment Management
CHRS icon

WCM Investment Management’s Coherus Oncology CHRS Stock Holding History

WCM Investment Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-126,176
Closed -$2.25M – 181
2020
Q2 		$2.25M Buy
126,176
+4,622
+4% +$78.2K 0.01% 149
2020
Q1 		$1.97M Buy
+121,554
New +$2.25M 0.01% 150

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

WCM Investment Management's CHRS Position: Q3 2020 in Review

WCM Investment Management sold out of Coherus Oncology (CHRS) in Q3 2020, closing a stake of 126,176 shares — an estimated $2.25M sold.

WCM Investment Management first reported a position in CHRS in Q1 2020 and held it in 2 quarters. The position peaked at $2.25M in Q2 2020. 201 funds tracked by Wall St. Rank hold CHRS as of Q3 2020.

  • WCM Investment Management reported no remaining Coherus Oncology position as of Q3 2020 after selling out during the quarter.
  • WCM Investment Management sold 126,176 Coherus Oncology shares in Q3 2020, an estimated $2.25M.
  • WCM Investment Management first reported a position in Coherus Oncology in Q1 2020 and held it in 2 quarters.
  • WCM Investment Management's Coherus Oncology position peaked at $2.25M in Q2 2020.
  • 201 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2020.

Based on WCM Investment Management's 13F filing for Q3 2020, filed 6 Nov 2020.